EcoDrugPlus

Vascular Endothelial Growth Factor A

Ensembl ID : ENSPKIG00000012831
Gene Symbol: VEGFA
3 Cross references
201 Possible Orthologues:

Vascular Endothelial Growth Factor A-A-Like

Ensembl ID : ENSPKIG00000025613
Gene Symbol: LOC111844528
3 Cross references
181 Possible Orthologues:

Vascular Endothelial Growth Factor Receptor 1-Like

Ensembl ID : ENSPKIG00000007915
Gene Symbol: LOC111837761
3 Cross references
198 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSPKIG00000018977
Gene Symbol: VDR
3 Cross references
457 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSPKIG00000015484
Gene Symbol: VDR
3 Cross references
457 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like Protein 1

Ensembl ID : ENSPKIG00000018541
Gene Symbol: LOC111836830
3 Cross references
190 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-1 Subunit-Like

Ensembl ID : ENSPKIG00000006111
Gene Symbol: LOC111848312
3 Cross references
194 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-3 Subunit-Like

Ensembl ID : ENSPKIG00000018667
Gene Symbol: LOC111849138
3 Cross references
254 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSPKIG00000007929
Gene Symbol: LOC111843200
3 Cross references
189 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-3-Like

Ensembl ID : ENSPKIG00000000712
Gene Symbol: LOC111848761
2 Cross references
220 Possible Orthologues:

Wee1-Like Protein Kinase 1-A

Ensembl ID : ENSPKIG00000022162
Gene Symbol: LOC111850524
3 Cross references
211 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSPKIG00000005109
Gene Symbol: XDH
1 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).